Sign in

You're signed outSign in or to get full access.

Eric L. Robinson

Chairman of the Board at CLEARONE
Board

About Eric L. Robinson

Eric L. Robinson (age 58) has served as a director of ClearOne, Inc. since July 2015 and has been Chairman of the Board since February 2022 . He is a corporate attorney by training (14 years in private practice, including 11 years as partner at Blackburn & Stoll, LC) with deep securities and transactional expertise; he holds a B.S. in Accounting (honors) from the University of Utah, passed the CPA exam (unlicensed), and earned a J.D. from Vanderbilt University (Order of the Coif; Managing Editor of the Law Review) . The Board has designated him as an “audit committee financial expert” .

Past Roles

OrganizationRoleTenureCommittees/Impact
Blackburn & Stoll, LCPartner (corporate/securities)11 yearsLed securities and corporate transactions
Private practiceCorporate Attorney14 yearsSecurities, corporate, M&A, licensing, construction contracts
ActiveCare, Inc.CFO, in-house counsel, secretary, treasurerJul 2016–Jun 2017Voluntary resignation; company filed Chapter 11 on Jul 15, 2018 (post-departure)
ClearOne, Inc. & E. Dallin BagleyCorporate/securities legal counselNot specifiedPrior counsel to CLRO and its largest shareholder (potential related-party sensitivity)

External Roles

OrganizationRoleTenureNotes
MicroPower Global LimitedGeneral Counsel, CFO, DirectorPast five yearsSemiconductor company
OUR Rescue, Inc.VP of Legal AffairsPast five yearsNon-profit sector
Various companiesCounselOngoingRegenerative medicine and commercial construction clients

Board Governance

CommitteeRoleIndependenceNotes
Audit and ComplianceChairIndependent (NASDAQ/SEC) Designated “audit committee financial expert”
CompensationMemberIndependent (NASDAQ) Oversees executive compensation; equity grant practices and peer benchmarking described
NominatingMemberIndependent (NASDAQ) Oversees director nominations and board composition
Special Transaction CommitteeMemberIndependent (NASDAQ) Formed Nov 2024 to review strategic alternatives
  • Board leadership separated: Robinson named independent Chairman in Feb 2022; roles of CEO and Chair are split .
  • Attendance: Board held 9 meetings in 2024; no director attended fewer than 75% of board/committee meetings; all directors attended the 2023 annual meeting .

Meetings (2024)

MetricCount
Board Meetings9
Audit & Compliance Committee Meetings4
Compensation Committee Meetings3
Nominating Committee Meetings0
Special Transaction Committee Meetings0

Fixed Compensation

Metric20222024
Fees Earned or Paid in Cash ($)$40,800 $70,200

Performance Compensation

Metric20222024
Option Awards ($)$13,200 $0
  • Option grants to directors provide accelerated vesting upon a change in control under certain awards .
  • The Compensation Committee did not employ compensation consultants in 2024 .

Other Directorships & Interlocks

OrganizationPublic?RoleInterlock/Conflict Consideration
MicroPower Global LimitedNot disclosedDirector; GC; CFONo specific conflict disclosed
OUR Rescue, Inc.Non-profitVP of Legal AffairsNo specific conflict disclosed
ClearOne & E. Dallin BagleyOutside legal counsel (prior)CounselPrior counsel to CLRO and largest shareholder; monitoring for related-party sensitivity advisable
  • Edward D. Bagley beneficially owns 49.60% of CLRO; he received $65,000 in consulting fees in 2024 under a long-running consulting agreement reviewed under the related-party policy .

Expertise & Qualifications

  • Corporate/securities law, M&A, licensing, construction contracts; 14 years in private practice; 11 years as law firm partner .
  • Financial expertise: prior CFO roles; B.S. Accounting (honors), passed CPA exam (unlicensed); designated audit committee financial expert .
  • Legal credentials: Vanderbilt J.D., Order of the Coif; Managing Editor of the Law Review .

Equity Ownership

Shares Owned CurrentlyCould be Acquired Within 60 DaysTotal Beneficial OwnershipPercent of Outstanding
65 38,333 38,398 0.14%
  • No disclosure of shares pledged as collateral; no pledging noted .
  • Insider Trading Policy imposes blackout periods and requires pre-approval for senior officers/key employees; trading while in possession of MNPI is prohibited .

Governance Assessment

  • Positives:
    • Independent director with “audit committee financial expert” designation; chairs Audit Committee; Board has separated CEO and Chair roles enhancing oversight .
    • Strong attendance and multi-committee engagement; active risk oversight through Audit and role on Special Transaction Committee .
    • Formal insider trading policy and related-party transactions policy with Audit Committee review .
  • Concerns/RED FLAGS:
    • Prior legal counsel to CLRO and to dominant shareholder Edward D. Bagley presents perceived conflict risk; rigorous recusal and committee oversight are essential .
    • Concentration of roles: Board Chair and Audit Committee Chair held by same individual concentrates governance power; some investors prefer these roles split .
    • Low personal ownership (0.14%; 65 shares currently owned) and no director equity awards in 2024 may limit economic alignment with shareholders .
    • Historical association with ActiveCare, Inc. (CFO) which later entered bankruptcy (post-departure) may be scrutinized by risk-sensitive investors .
    • Absence of external compensation consultants in 2024 could suggest limited external benchmarking rigor for pay decisions .
    • High shareholder concentration (Bagley at 49.60%) heightens importance of independent committee processes, especially for strategic transactions overseen by the Special Transaction Committee .